Your browser doesn't support javascript.
loading
Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer.
Rasola, Cosimo; Laurent-Puig, Pierre; André, Thierry; Falcoz, Antoine; Lepage, Come; Aparicio, Thomas; Bouché, Olivier; Lievre, Astrid; Mineur, Laurent; Bennouna, Jaafar; Louvet, Christophe; Bachet, Jean Baptiste; Borg, Christophe; Vernerey, Dewi; Lonardi, Sara; Taieb, Julien.
Afiliação
  • Rasola C; Department of Gastroenterology and GI Oncology, Georges Pompidou European Hospital, SIRIC CARPEM, Université Paris-Cité, Paris, France; Department of Oncology, Veneto Institute of Oncology IRCCS, Padua, Italy; Medical Oncology 3, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy; Department of Su
  • Laurent-Puig P; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université de Paris Cité, team Personalized Medicine, Phamacogenomics and Therapeutic Optimization, Paris, France; Institut du Cancer Paris CARPEM, AP-HP,Centre Department of Gastroenterology and Digestive Oncology, Hôpital Européen Ge
  • André T; Sorbonne Université and Medical Oncology Department, Hôpital Saint-Antoine, Paris, France.
  • Falcoz A; University Hospital of Besançon, Methodology and Quality of Life Unit in Oncology, Besançon, France; INSERM, Établissement Français du Sang Bourgogne Franche-Comté, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
  • Lepage C; Gastroenterology and Digestive Oncology, Hôpital Universitaire Le Bocage, Dijon, France.
  • Aparicio T; Université Paris-Cité, Gastroenterology Department, Hôpital Saint Louis, APHP, Paris, France.
  • Bouché O; Dept of Digestive Oncology, CHU Reims, Reims, France.
  • Lievre A; Digestive Unit, Hôpital Universitaire de Pontchaillou, Rennes, France.
  • Mineur L; Oncology Department, Clinique Sainte-Catherine, Avignon, France.
  • Bennouna J; Department of Medical Oncology, Hôpital Foch, Suresnes, France.
  • Louvet C; Department of Medical Oncology, Institute Mutualiste Montsouris, Paris, France.
  • Bachet JB; Sorbonne University, Hepatogastroenterology and Digestive Oncology Department, Pitié Salpêtrière hospital, APHP, Paris, France.
  • Borg C; Department of Medical Oncology, University Hospital of Besançon, France.
  • Vernerey D; University Hospital of Besançon, Methodology and Quality of Life Unit in Oncology, Besançon, France; INSERM, Établissement Français du Sang Bourgogne Franche-Comté, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
  • Lonardi S; Department of Oncology, Veneto Institute of Oncology IRCCS, Padua, Italy; Medical Oncology 3, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Taieb J; Department of Gastroenterology and GI Oncology, Georges Pompidou European Hospital, SIRIC CARPEM, Université Paris-Cité, Paris, France. Electronic address: jtaieb75@gmail.com.
Eur J Cancer ; 194: 113321, 2023 11.
Article em En | MEDLINE | ID: mdl-37797388
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Neoplasias do Colo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Neoplasias do Colo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article